Treatment of central sensitization in patients with ‘‘unexplained’’ chronic pain: what options do we have?

Author： Nijs Jo   Meeus Mira   Van Oosterwijck Jessica   Roussel Nathalie   De Kooning Margot   Ickmans Kelly   Matic Milica  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.7, 2011-05, pp. : 1087-1098

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic neuropathic pain may persist in patients who have completed leprosy treatment

By  

Inpharma, Vol. 1, Iss. 1257, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Antimicrobial resistance - why do we have it and what can we do about it?

By Dougherty T.J.   Pucci M.J.   Bronson J.J.   Davison D.B.   Barrett J.F.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1707-1709

Informa Healthcare

Access to resources Recommend Favorite

Do beta-blockers have a role in the treatment of chronic heart failure?

By Panfilov V.   Olsson G.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 1, 1997-01 ,pp. : 23-30

Informa Healthcare

Access to resources Recommend Favorite

Is Time to Change to Halogenated Drugs in Cardiac Surgery, What do we have to do with Propofol?

By  

Current Pharmaceutical Design, Vol. 20, Iss. 34, 2014-10 ,pp. : 5497-5505

Bentham Science Publishers

Access to resources Recommend Favorite

Biomarkers Obtained by Non-Invasive Methods in Patients with COPD: Where do we Stand, what do we Expect?

By  

Current Medicinal Chemistry, Vol. 16, Iss. 22, 2009-08 ,pp. : 2824-2838

Bentham Science Publishers

Access to resources Recommend Favorite